发明授权
US09133143B2 (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredient for the diagnosis or treatment of neurodegenerative brain diseases
有权
(3-氟-2-羟基)丙基官能化的芳基衍生物或其药学上可接受的盐,其制备方法和含有作为神经变性性脑病诊断或治疗的活性成分的药物组合物
- 专利标题: (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredient for the diagnosis or treatment of neurodegenerative brain diseases
- 专利标题(中): (3-氟-2-羟基)丙基官能化的芳基衍生物或其药学上可接受的盐,其制备方法和含有作为神经变性性脑病诊断或治疗的活性成分的药物组合物
-
申请号: US13505159申请日: 2010-09-14
-
公开(公告)号: US09133143B2公开(公告)日: 2015-09-15
- 发明人: Dae-Yoon Chi , Byoung-Se Lee , Sirion Uthaiwan , So-Young Chu , Yu-Jin Bae , Chansoo Park , Dae-Hyuk Moon , Jin-Sook Ryu , Jae-Seung Kim , Seung-Jun Oh
- 申请人: Dae-Yoon Chi , Byoung-Se Lee , Sirion Uthaiwan , So-Young Chu , Yu-Jin Bae , Chansoo Park , Dae-Hyuk Moon , Jin-Sook Ryu , Jae-Seung Kim , Seung-Jun Oh
- 申请人地址: KR Incheon
- 专利权人: FUTURECHEM CO., LTD.
- 当前专利权人: FUTURECHEM CO., LTD.
- 当前专利权人地址: KR Incheon
- 代理机构: Renner, Otto, Boisselle & Sklar, LLP
- 优先权: KR10-2009-0103668 20091029
- 国际申请: PCT/KR2010/006252 WO 20100914
- 国际公布: WO2011/052888 WO 20110505
- 主分类号: C07D417/04
- IPC分类号: C07D417/04 ; A61K31/4436 ; C07D277/66 ; C07D409/04 ; C07D471/04
摘要:
The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases. The aryl derivatives of the present invention are (3-fluoro-2-hydroxy)propyl-functionalized to increase the polarity thereof, and therefore the drugs containing the aryl derivatives can easily permeate into the cerebrovascular membrane, thus increasing the effectiveness of the drugs. As the aryl derivatives of the present invention strongly bind to β-amyloid, the aryl derivatives, when labeled with radioisotope, can be used as a diagnostic agent for non-invasively diagnosing early Alzheimer's disease. Further, the aryl derivatives of the present invention bind to low molecular β-amyloid peptide conjugates to inhibit the generation of malignant high molecular β-amyloid plaque, and thus can be effectively used as a therapeutic agent for neurodegenerative brain diseases such as Alzheimer's disease.
信息查询